AMERICAN CENTURY COMPANIES INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$2,446,251
+45.0%
27,308
+37.8%
0.00%
+100.0%
Q2 2023$1,687,305
+49.9%
19,818
+41.1%
0.00%0.0%
Q1 2023$1,125,827
+9.9%
14,043
+7.8%
0.00%0.0%
Q4 2022$1,024,495
+28.4%
13,026
+20.9%
0.00%0.0%
Q3 2022$798,000
+45.4%
10,778
+28.0%
0.00%
Q2 2022$549,000
-50.1%
8,422
-51.6%
0.00%
-100.0%
Q1 2022$1,100,000
+214.3%
17,407
+163.5%
0.00%
Q4 2021$350,000
-2.5%
6,605
+29.9%
0.00%
Q3 2021$359,000
+20.5%
5,084
+13.6%
0.00%
Q2 2021$298,000
-16.8%
4,477
+38.7%
0.00%
Q1 2021$358,000
-99.7%
3,227
-99.7%
0.00%
-100.0%
Q3 2019$116,785,000
+5.5%
925,833
+0.7%
0.12%
+6.4%
Q2 2019$110,677,000
+51.6%
919,706
+10.2%
0.11%
+48.6%
Q1 2019$73,029,000
-5.9%
834,811
+7.6%
0.07%
-16.9%
Q4 2018$77,634,000
-32.6%
775,955
-22.9%
0.09%
-20.5%
Q3 2018$115,243,000
+323.0%
1,005,784
+231.1%
0.11%
+314.8%
Q2 2018$27,246,000
+211.7%
303,808
+154.3%
0.03%
+200.0%
Q1 2018$8,741,000
-22.0%
119,484
-38.1%
0.01%
-18.2%
Q4 2017$11,210,000
+402.7%
193,013
+288.3%
0.01%
+450.0%
Q3 2017$2,230,000
+22.1%
49,704
+7.4%
0.00%0.0%
Q2 2017$1,827,000
-1.8%
46,271
+0.9%
0.00%0.0%
Q1 2017$1,860,000
+1.8%
45,846
+0.9%
0.00%0.0%
Q4 2016$1,827,000
-75.6%
45,441
-82.4%
0.00%
-77.8%
Q2 2016$7,493,000
-62.3%
258,474
-54.5%
0.01%
-60.9%
Q1 2016$19,880,000
+4.0%
568,318
-4.2%
0.02%
+4.5%
Q4 2015$19,119,000
+16.1%
593,020
+16.4%
0.02%
+10.0%
Q3 2015$16,469,000
-19.5%
509,546
+3.1%
0.02%
-13.0%
Q2 2015$20,450,000
-19.4%
494,430
-12.5%
0.02%
-17.9%
Q1 2015$25,382,000
-19.3%
565,040
-32.8%
0.03%
-20.0%
Q4 2014$31,463,000
-6.4%
840,818
-12.7%
0.04%
-10.3%
Q3 2014$33,618,000
+4.0%
962,723
+5.0%
0.04%
+5.4%
Q2 2014$32,333,000
+433.6%
916,465
+393.0%
0.04%
+428.6%
Q1 2014$6,059,000
+236.2%
185,905
+311.5%
0.01%
+250.0%
Q3 2013$1,802,000
-37.5%
45,180
-35.2%
0.00%
-50.0%
Q2 2013$2,885,00069,7600.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders